News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
About the Author - Alex Keown

news@biospace.com

BioSpace News - By Alex Keown
Filings Reveal Bristol-Myers Squibb (BMY) Passes on Option to Buy f-Star 4/28/2017
Why Bristol-Myers Squibb (BMY) Just Became an Even More Attractive Takeover Target 4/28/2017
Biotech Unicorn Moderna's Vaccine Performs Well in First Human Trial 4/28/2017
AstraZeneca PLC (AZN) Dumps Two Drugs From Pipeline, Causing an Ex-Partner's Stock to Tank Some More 4/27/2017
Biogen (BIIB)'s Ex-CEO George Scangos Left a Very Wealthy Man 4/27/2017
Massachusetts' Avedro Banks $42 Million, Opens New Facility and Will Continue to Expand Its Team 4/27/2017
9 Top Biotechs That Have Stashed Away a $133 Billion M&A Cashpile Overseas 4/27/2017
AstraZeneca PLC (AZN)'s Cambridge Headcount Hits 2,000 as Its New HQ Hit Budget Woes 4/27/2017
AstraZeneca PLC (AZN)'s Lung Cancer Trial Gets Delayed 4/27/2017
Regeneron (REGN)'s Top Execs Get a Huge Pay Cut in 2016 But It's Still More Than Most of Us Have Ever Dreamed of 4/27/2017
Beleaguered Bay Area Pharma OncoMed (OMED) Lays Off Half Its Workforce 4/26/2017
Texas-based ePatientFinder CEO Looks to Revolutionize Clinical Trial Recruitment 4/25/2017
Now Theranos is Accused of Running Fake Tests and Setting Up Secret Company 4/25/2017
Germany's Fresenius Kabi AG Slams Down $4.3 Billion for Akorn (AKN) in U.S. Expansion 4/25/2017
Ophthotech (OPHT) Co-Founder and CEO to Step Down, CFO Named New Leader 4/25/2017
Trump Invites Top Biotech Execs and Researchers for Meeting at the White House Next Month 4/25/2017
Unstoppable Celgene (CELG) to Take Over Amgen (AMGN)'s Former Space in Cambridge 4/24/2017
Turing CEO and Shkreli Associate Exits Top Post, CSO Takes Over 4/24/2017
Elon Musk Outlines Plans for Bay Area Brain Implants Startup Neuralink 4/24/2017
Novartis AG (NVS) Hires Bank of America (BAC) to Officially Review Alcon (ACL) Options 4/24/2017
Up to 4,100 Children Victims of Sanofi (SNY)'s Epilepsy Drug, Says French Regulator 4/21/2017
Editas Medicine (EDIT), Veritas Genetics Co-Founder and Biotech Phenom George Church Makes Time's 100 'Most Influential' List 4/21/2017
Investors Accuse Theranos of Threatening to File for Bankruptcy If They Didn't Give Up Their Right to Sue 4/21/2017
Bay Area's Atara Biotherapeutics (ATRA) Leases Huge Space in SoCal 4/20/2017
AbbVie (ABBV)'s PARP Inhibitor Fails to Deliver in Two Late-Stage Studies 4/20/2017
Juno (JUNO) Taps Ex-Genentech (RHHBY) Scientist to Head Up R&D at New Bay Area Office 4/20/2017
Johnson & Johnson (JNJ) Hosts 'Shark-Tank'-Like Competition and Crowned This Biotech Startup as Its Winner 4/20/2017
Tension Rises Between Vertex (VRTX) and Its Religious Investors Over Lobbying Disclosures 4/20/2017
Where Billionaire-Led Intrexon (XON) Could Be in 10 Years 4/20/2017
Cancer Biotech G1 Therapeutics Files for $115 Million IPO 4/19/2017
Antibiotics Maker Steri-Pharma Wants to Create 72 New Jobs in New York 4/19/2017
This Year’s Superbug Norovirus Sickens Hundreds of Millions, Prompting Urgent Race for Vaccine 4/18/2017
Getting Off Easy? Embattled Theranos Could Have a Lab Again in 2019 4/18/2017
Hanmi Pharma (128940.KS) Charged for Failure to Report Patient Death in Olmutinib Study 4/18/2017
When It Rains, It Pours: Bay Area's OncoMed (OMED) Tanks Again as Lung Cancer Med Fails Phase II, Discontinues Phase I Study 4/18/2017
Pharma Giant Merck Sharp & Dohme (MRK) Could Bring 600 New Jobs to Austin 4/18/2017
Genentech (RHHBY) Shows Off Late-Stage Hemophilia A Data 4/17/2017
Drug Giant Aspen Pharmacare Plotted to Destroy Cancer Medicine to Jack Up Prices 4/17/2017
Boston's SV Life Sciences Unveils Name Change, Debuts $400M Fund for Biotech 4/14/2017
Abbott (ABT) Seals Alere (ALR) Deal at Lower Price, Ending Legal Battle 4/14/2017
2 Drugmakers Seek to Block Arkansas from Using Their Drugs to Execute 7 Men 4/14/2017
Nexvet Stock Skyrockets on $85 Million Takeover Offer from Zoetis (ZTS) 4/14/2017
Biotech Startup Vyriad Graduates from Mayo Clinic Incubator to Larger Space 4/13/2017
Wait For It! Trump Tapped Congressman to Become the Next 'Drug Czar' 4/13/2017
It's Official: Ovid CEO Just Filed for $86 Million IPO 4/13/2017
It's Not Over Yet: Martin Shkreli Stays Mum on Plans for New Biotech Software Company 4/13/2017
Boston's PureTech Gives Birth to New Biotech and Its Name is Nybo Therapeutics 4/12/2017
SEC Cracks Down on "Fake Biotech News" 4/12/2017
Shutdown Looming: Unilife  (UNIS) Files for Chapter 11 4/12/2017
Bay Area Avinger Cuts Workforce by 33% 4/12/2017
FDA Picks Boston's Emulate for its Organ-on-a-Chip Technology 4/12/2017
3 Drug Giants That Boasts the Best Pipelines 4/11/2017
Takeda (TKPYY) Splits Off a Range of Businesses to Focus on R&D 4/11/2017
These 3 Big Biotechs Could Have New Blockbuster Drugs Very Soon 4/10/2017
Finally! STADA Arzneimittel (STAGn.DE) Accepts $5.6 Billion Takeover Offer From Bain, Cinven 4/10/2017
FDA Finally Allows 23andMe to Sell At-Home DNA Tests for 10 Diseases 4/10/2017
Johnson & Johnson (JNJ) Forges Peptide Discovery Pact Worth $1.5 Billion With Japanese Biopharma Peptidream 4/7/2017
Elizabeth Holmes Now Owes Theranos $25 Million 4/7/2017
FDA Calls Regeneron (REGN)'s Evinacumab a Breakthrough 4/7/2017
Massive $1.2 Billion Biotech Center in New York Will Create Thousands of New Jobs 4/7/2017
One of the Most Controversial Drug Companies in America Is Out of the Industry's Lobby 4/7/2017
Halozyme (HALO) CEO: PEGPH20 Bolsters Checkpoint Inhibitors in Preclinical Data 4/6/2017
Sexual Harassment Claims Lead Eli Lilly (LLY), Pfizer (PFE), Sanofi (SNY) and More to Pull the Plug on Ads From Bill O'Reilly's Show 4/6/2017
Why Bill Ackman Really Left Valeant (VRX) 4/6/2017
On Display Today: President Trump's FDA Nominee Has Ties to These Companies 4/6/2017
Unilife  (UNIS) Slashes Workforce and May Not Have Enough Cash to Survive Beyond This Week 4/5/2017
Astellas (ALPMY) Takes Out Belgium Biotech in Deal Worth $853 Million 4/5/2017
World's Richest Doctor Allegedly Threatened to Abandon Investment Unless Troubled Media Firm Invested in NantKwest 4/4/2017
This Little-Known $12 Billion SoCal Startup Wants to Cure Baldness and Smooth Out Your Wrinkles 4/4/2017
Bristol-Myers Squibb (BMY)'s Next Big Bet After Opdivo Failure—IDOs 4/4/2017
Teva (TEVA) Finally Wins FDA Approval for Potential Huntington’s Blockbuster Austedo 4/4/2017
President Trump's Right-Hand Woman, Kellyanne Conway Consulted for Nation’s Leading Science Group 4/3/2017
Novartis AG (NVS) Looks Over Its Shoulder as Kite Pharma (KITE) Hits Its BLA Filing Deadline 4/3/2017
A Look at Biogen (BIIB)'s Big Bet on the Holy Grail of Science—Alzheimer's 3/29/2017
Elon Musk Launches Neuroscience Startup to Plug AI Into Your Brain 3/29/2017
FDA Clears Massachusetts Biotech Tesaro (TSRO)'s Ovarian Cancer PARP Inhibitor 3/29/2017
Drug Giant Amgen (AMGN) to Create Hundreds of New Jobs in Florida 3/29/2017
Nearly 500 Amgen (AMGN) Staffers to be Reassigned, Relocated or Laid Off in Restructuring 3/28/2017
Questions Arise Over the World's Richest Doctor's 'Breakthrough' Cancer Therapy Promo Videos 3/28/2017
Media Mogul Rupert Murdoch Dumps $125 Million Theranos Stake for $1 3/28/2017
These Two Drugmakers Have Even More Debt Than Valeant (VRX) 3/28/2017
Former Baxalta (BXLT) CEO to Helm Struggling Alexion (ALXN) 3/28/2017
Theranos CEO Gives Up Own Shares to Investors to Avoid Being Sued 3/27/2017
Despite Recent Layoffs, Eli Lilly (LLY) to Invest $850 Million in U.S. Operations 3/24/2017
Bay Area's Ultragenyx (RARE) Tanks as Seizure Drug Flunks Phase II Test 3/24/2017
Boston's Paratek Pharma (PRTK) Expands Pennsylvania Operations With 30 Employees, Can Accommodate 100 3/24/2017
5 Biotechs That Have Major Catalysts Coming in the Next 6 to 9 Months 3/24/2017
Google (GOOG)'s Verily Employees Make Themselves at Home at Onyx (AMGN)'s Former HQ 3/24/2017
Reverse Merger With DARÉ Bioscience Gives Cerulean (CERU) Execs a Parting Gift—Bonuses 3/23/2017
Why Struggling Bristol-Myers Squibb (BMY) Could Take Out This Danish Biotech in Major €500M Deal 3/23/2017
How Biogen (BIIB) Spinoff Bioverativ (BIVVV) and Its Hemophilia Med Could Make This Biotech Bleed 3/23/2017
UCSF Heart Doctor Wary of Amgen (AMGN)-Paid Repatha Study 3/23/2017
Filing Shows Money Woes May Force NeuralStem to Halt Trials, Cease Operations or File for Bankruptcy 3/23/2017
How This Drug Candidate Could be a Winner in Gilead (GILD)'s Pipeline 3/23/2017
Intellia’s CEO Has Cambridge-Based Company Moving Forward on Positive in vivo Data 3/22/2017
Heat Biologics (HTBX) Rockets as Lung Cancer Med Hits Mid-Stage Goals 3/22/2017
Filings Reveal Alnylam (ALNY) CEO's Pay Dropped Almost 80% in 2016 3/22/2017
Cerulean (CERU) to Slash More Than Half of Its Remaining Staff, Merge With SoCal Biotech 3/21/2017
Trump Budget Would Double FDA Product Review Fees, Leading to Faster Drug Approvals 3/21/2017
Bay Area's CytomX (CTMX) Surges as Bristol-Myers Squibb (BMY) Signs Up for 8 More Projects With $200 Million Upfront in Deal Totaling $5 Billion 3/20/2017
Trump's Expected Policy Changes Have Propelled These 2 Biotechs to New Highs 3/20/2017
Why This Biotech Says It's Close to Curing the Type of Cancer That Killed Steve Jobs 3/20/2017
Crippled Bay Area Pharma Threshold (THLD) Rockets on Reverse Merger Deal With Molecular Templates 3/20/2017
The Hype Behind Massachusetts Biotech Corbus (CRBP)' Sole Pipeline Drug 3/20/2017
How 3 Laid Off Employees Turned Pfizer (PFE)'s Discarded Compounds Into Novartis AG (NVS) Gold 3/17/2017
World's Smartest Billionaire Upped Position in This Bay Area Biotech 3/17/2017
Major Reorganization to Hit the NIH, Deep Cuts to Affect Thousands Under Trump Budget Plan 3/17/2017
AstraZeneca PLC (AZN) Steals Tesaro (TSRO)'s PARP Thunder With Phase III Ovarian Cancer Data 3/16/2017
Lawmakers Question the FDA's "Unusual" Approval of Marathon Pharma's Controversial Old DMD Drug 3/16/2017
Bernie Sanders: Trump Must Stop Sanofi (SNY)'s Exclusive Zika Deal 3/15/2017
What a Gilead (GILD)-Incyte (INCY) Marriage Would Look Like 3/15/2017
GlaxoSmithKline (GSK)'s First Woman CEO Will Get a Smaller Paycheck Than (Male) Predecessor 3/15/2017
Ackman Is Finally Done With Valeant (VRX), Takes $2.8 Billion Loss and Will Step Down From Board 3/14/2017
It's Official: Trump Nominates Scott Gottlieb for Top FDA Job 3/14/2017
FDA Demands Karyopharm (KPTI) Stop Enrollment of All Selinexor Trials 3/14/2017
Why an Acquisition of This CAR-T Biotech Makes Sense 3/14/2017
Shakeup at Intrexon (XON) as a Subsidiary is Created and an Ex-Pfizer (PFE) Exec Exits in Reorg 3/14/2017
A Win for venBio as Judge Hits Pause on Immunomedics (IMMU)'s $2 Billion Deal With Seattle Genetics (SGEN) 3/13/2017
Boston Scientific (BSX) Commits to 10 More Years in SoCal Space, Plans to Hire 3/10/2017
Trump's Pick for New FDA Head Getting Down to the Wire 3/10/2017
Painful Setbacks Lead Bristol-Myers Squibb (BMY) to Bring in a New R&D Chief 3/10/2017
C-Suite Shakeup: Novogen (NVGN) CEO North America, CSO and CFO Exit in Reorg 3/10/2017
Pfizer (PFE) Eyes $100 Million Expansion, New Jobs in North Carolina 3/10/2017
Oscar Winner Turned Pharma CEO: We’ll Prevent Genital Herpes 3/10/2017
Retrophin (RTRX) to Close Down Cambridge Operations, Cut Jobs in Consolidation Move 3/10/2017
Merck KGaA (MKGAF.PK) in Deep Talks to Sell Biosimilars Unit 3/10/2017
AstraZeneca PLC (AZN) Had 'Fake Doctor' Under Payroll in Australia 3/9/2017
Backed by Google (GOOG), Cambridge's Spero Nabs $51.7 Million Series C 3/8/2017
NantHealth (NH) Founder Patrick Soon-Shiong Calls Report on Fund Diversion 'Maliciously False' 3/8/2017
World's Richest Doctor Accused of Diverting Donations Back to His Own Companies 3/8/2017
Why Pharma Giant AstraZeneca PLC (AZN)'s Market Value Gained $3.8 Billion Last Month 3/7/2017
Amgen (AMGN) Files Trade Secret Action Against Bay Area's Coherus 3/7/2017
2 Tempting Biotech Stocks to Avoid Like Mad 3/7/2017
Why Ex-Mayor Peterson is Stepping Down From Eli Lilly (LLY) After 7 Years On the Job 3/7/2017
Chinese Billionaire's Biotech Hutchison China MediTech (Chi-Med) Shows Off Phase III Cancer Drug Data 3/6/2017
Biotech Guru's Roivant Sciences Could Soon Double Its Headcount in North Carolina 3/6/2017
Why This Alzheimer's Biotech May Not Live to See 2020 3/6/2017
Following Up on Bristol-Myers Squibb (BMY)'s Restructuring Plans, Company Makes Move to Shift 1,250 Workers Out of Hopewell Township Site 3/6/2017
Short Sellers Load Up on Pfizer (PFE) After Buyout Rumors 3/6/2017
Juno (JUNO) Finally Drops Problem CAR-T Drug That Caused Deaths 3/3/2017
10 Biotechs With an Orphan Drug in Late-Stage Pipeline 3/3/2017
Novartis AG (NVS) Puts Cancer Hopes on 4 Star Scientists Poached From Harvard Last Year 3/3/2017
9 Massachusetts Biotechs Facing Major FDA Decisions This Year 3/3/2017
Genentech (RHHBY) New Breast Cancer Cocktail Cuts Deaths in Phase III Study, Roche (RHHBY) Stock Soars 3/3/2017
Backed by Amazon (AMZN) and Big Names Like Bristol-Myers Squibb (BMY), Celgene (CELG) and Merck & Co. (MRK), Bay Area's GRAIL Banks $900 Million 3/3/2017
Kite Pharma (KITE)'s CAR-T Blood Cancer Candidate Succeeds in Major Study 3/2/2017
6 Biotechs Facing Key FDA Decisions in March 3/2/2017
Why a Double-Digit Job Growth is Set to Hit This Biotech Hub 3/2/2017
Pfizer (PFE)'s Kansas Plant is 'Out of Control' and Puts Patients at Risk, Says the FDA 3/2/2017
Avoid These 3 Biotech Stocks Like the Plague 3/2/2017
Trump Takes Another Shot at the FDA's 'Slow And Burdensome' Approval Process 3/1/2017
Veloxis Pharma (VELO) to Shut Down New Jersey Office, Moving All Operations to North Carolina 3/1/2017
Exclusive: Janssen Pharmaceutical Just Came Clean on Drug Pricing Data 3/1/2017
Perrigo (PRGO) Cuts 750 Jobs, Sells MS Drug Royalties for $2.85 Billion and Loses CFO to Amgen (AMGN) 3/1/2017
The 5 Drug Giants That Could Snap Up a Struggling Bristol-Myers Squibb (BMY) 3/1/2017
Merck & Co. (MRK), Eli Lilly (LLY) Failure Puts Alzheimer's Drug Development Spotlight on Rival Genentech (RHHBY) 3/1/2017
Troubled Cempra (CEMP) Slashes 67% of Workforce 3/1/2017
Momenta (MNTA) to Become Neighbors With Biogen (BIIB), Ironwood (IRWD) in Kendall Square Next Year 2/28/2017
A Look Inside Takeda (TKPYY)'s Remarkable R&D Transformation 2/28/2017
Bayer (BAY)'s Job Cuts at Mission Bay Campus Leaves Room for New Bay Area Startups 2/28/2017
CRISPR/Cas9 Startup Exonics Therapeutics Launches in Boston 2/28/2017
Biotech Vets Launch Arrakis Therapeutics With $38 Million and Will be Helmed By Biogen (BIIB) Alum Michael Gilman 2/28/2017
Ohr Pharma (OHRP) Suspends Work at San Diego Lab 2/27/2017
Buyers Remorse: Merck & Co. (MRK) Takes $2.9 Billion Charge on Hepatitis C Drug Inherited From $3.9 Billion Idenix (IDIX) Buy 2/27/2017
6 Biotechs Set Up Shop and Create Jobs in Buffalo, New York 2/27/2017
Surprising Departure: Celgene (CELG) President and COO "Retiring" in the Summer 2/27/2017
50+ Valeant (VRX) Sales Reps May Have Jumped Ship to Synergy Pharma (SGYP) 2/24/2017
Backed by Johnson & Johnson (JNJ), Fusion Pharma Launches With $25 Million 2/24/2017
The End of the Road: New Jersey's NovaDel Pharma (NVD) to Dissolve 2/24/2017
North Korean Biotech Institute Allegedly Involved in the Killing of Leader Kim Jong-Un's Half Brother 2/23/2017
Serial Investor Carl Icahn Takes Stake in Bristol-Myers Squibb (BMY), Stock Jumps 2/23/2017
Pfizer (PFE), Celgene (CELG), Eli Lilly (LLY), Merck & Co. (MRK) CEOs and Other Execs Send Letter Supporting GOP Tax Plan 2/22/2017
Why This UC Berkeley Scientist is Planning to Take on Washington in 2018 2/22/2017
How Much Money Embattled Theranos Has Left in the Bank 2/21/2017
Rumored Acquisition Target Bristol-Myers Squibb (BMY) Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback 2/21/2017
Meet the Professor Who Was the First to Question Theranos' Research 2/21/2017
Zoning Changes Kills Sale of Bristol-Myers Squibb (BMY)'s Connecticut Campus 2/21/2017
What This Contender for FDA's Top Job Could Do His First 6 Months on the Gig 2/21/2017
Why Startup Cue BioPharma Picked Daniel Passeri as Its New CEO 2/21/2017
Norwegian Biotech Upstart Has Become a Potential Takeover Target 2/21/2017
Swiss Biotech Santhera (SANN.SW) Opens Up 20 Employee Shop in Massachusetts, Has Plans to Grow 2/20/2017
Questions Arise Over a Congressman's Ties With Australian Biotech Innate Immunotherapeutics 2/20/2017
3 Biotechs With the Biggest and Most Promising Pipelines 2/20/2017
AstraZeneca PLC (AZN) Investors Pumped as Breast Cancer Drug Sails Through Phase III Trial 2/20/2017
Woman to Watch: Meet the Woman Who is Helming Boston's Cocoon Biotech 2/20/2017
AMAG (AMAG) to Hire 150 New Sales Reps to Support New Drug Intrarosa 2/17/2017
ArmaGen CEO: Phase II Data Shows Cognitive Improvement in Juvenile Hurler Syndrome Patients 2/16/2017
Bristol-Myers Squibb (BMY) May Be on the Market, But Pfizer (PFE) Probably Won't Bite 2/16/2017
Another Drug Bites the Dust: Merck & Co. (MRK) Stops Late-Stage Alzheimer’s Study 2/16/2017
Bristol-Myers Squibb (BMY) Could Finally Go on the Market; Rumored Suitors Include Gilead (GILD), Pfizer (PFE), Novartis AG (NVS) and Roche (RHHBY) 2/16/2017
Questions Remain Over Suicide Death of Genentech (RHHBY) Lobbyist 2/16/2017
This is Why the Decision on Who Invented CRISPR Matters 2/16/2017
First Ariad (ARIA), Now Senator Bernie Sanders Puts This Drug Company on Notice 2/16/2017
Ipsen (IPN.PA) Agrees to Hire 100 Merrimack (MACK) Employees Under $575 Million Cancer Deal 2/15/2017
Former Celgene (CELG) and Medtronic (MDT) CEOs Just Acquired This Maryland Biotech 2/15/2017
Roche (RHHBY) Faces Off With Itself for $9 Billion Breast Cancer Drug Business 2/15/2017
2 Biotechs Taking on the $20 Billion Alzheimer's Market Full Force 2/15/2017
Struggling Teva (TEVA) Mulls Over Sale, Spinoff of Branded Generics Biz 2/14/2017
Eli Lilly (LLY) Quells Rumors Regarding Multi-Million Irish Expansion Plan 2/14/2017
Oops, They Did it Again: Theranos Failed to Inform Patients of Potentially Botched Diabetes Test 2/14/2017



//-->